CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key market benefits
1.3 Key market segments
1.4 Key audiences
1.5 Research methodology

1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL IVF DEVICES & CONSUMABLES MARKET OVERVIEW

3.1 Market definition and scope
3.2 Alternative technologies

3.2.1 Intrauterine Insemination (IUI) Technique

3.2.1.1 Factors assessed for the procedure
3.2.1.2 Benefits of this technique
3.2.1.3 Risks

3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique

3.2.3.1 Difference between GIFT and IVF technique

3.2.4 ZIFT technique

3.2.4.1 Differences between ZIFT and IVF technique

3.3 Replacing IVF procedures by fertility drugs and surgeries

3.3.1 Female infertility treatments

3.3.1.1 Limitations of fertility drugs

3.3.2 Male infertility treatments

3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market

3.5.1 Egg donation
3.5.2 Egg sharing
3.5.3 Sperm donation
3.5.4 Embryo donation/adoption
3.5.5 Donation for research

3.6 Surrogacy

3.6.1 Legal issues

3.7 IVF trends in same sex couples

3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization

3.8 Advanced IVF technologies

3.8.1 Capsule IVF
3.8.2 Three parent IVF

3.8.2.1 Ethical concerns

3.8.3 Mini IVF

3.8.3.1 Advantages
3.8.3.2 Drawbacks

3.8.4 EmbryoScope

3.8.4.1 Advantages

3.8.5 PICSI

3.9 Fertility treatment and gender selection

3.9.1 Methods of sex selection

3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues

3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Key Findings

3.13.1 Top factors impacting
3.13.2 Top investment pockets
3.13.3 Top winning strategies

3.14 Porters five forces analysis

3.14.1 High competition and large number reduces the power of suppliers
3.14.2 Scattered nature and large count of end users moderates the buyer power
3.14.3 High capital cost lowers the threat of new entrants
3.14.4 Industry rivalry is intense due to presence of few dominant competitors
3.14.5 Lack of efficient substitutes lowers the threat from substitutes

3.15 Value chain analysis
3.16 Patent analysis

3.16.1 Patent analysis by type of patents
3.16.2 Patents Analysis by geography

3.17 Regulatory issues and legislations
3.18 Insurance reimbursement scenario
3.19 Clinical trials

3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures

3.20 Drivers

3.20.1 Delayed pregnancies in women
3.20.2 Rise in global infertility rates
3.20.3 Advancement in technology
3.20.4 Rise in gamete donations
3.20.5 Rise in disposable income
3.20.6 Increase in success rates

3.21 Restraints

3.21.1 Cost constraints
3.21.2 Ethical and legal issues
3.21.3 Multiple pregnancies
3.21.4 Low awareness level

3.22 Opportunities

3.22.1 Fertility tourism
3.22.2 Growing number of fertility clinics
3.22.3 Rise in same sex marriages

CHAPTER 4 GLOBAL IVF DEVICES & CONSUMABLES MARKET BY INSTRUMENTS

4.1 Global IVF market by instrument, 2014-2020, ($million)

4.1.1 Incubators

4.1.1.1 Global IVF incubators market by geography

4.1.2 Cryosystem

4.1.2.1 Global IVF cryosystem market by geography

4.1.3 Imaging system

4.1.3.1 Global IVF Imaging system market by geography

4.1.4 Cabinet (work station)

4.1.4.1 Global IVF cabinets market by geography

4.1.5 Ovum aspiration pump

4.1.5.1 Global IVF ovum aspiration pump market by geography

4.1.6 Sperm separation system

4.1.6.1 Global IVF Sperm separation system market by geography

4.1.7 Micro manipulator system

4.1.7.1 Global IVF Micromanipulator market by geography

4.1.8 Others

4.1.8.1 Global IVF other instruments market by geography

4.2 Accessories and disposables

4.2.1 Semen analysis chamber
4.2.2 Plastic ware
4.2.3 Oocyte retrieval needles
4.2.4 Miscellaneous disposables
4.2.5 Global IVF accessories and disposables market by geography

CHAPTER 5 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY REAGENTS & MEDIA

5.1 Global IVF market by reagents & media, 2014-2020, ($million)
5.2 Cryopreservation media

5.2.1 Embryo cryopreservation media
5.2.2 Sperm cryopreservation media
5.2.3 Oocyte cryopreservation media
5.2.4 Global IVF cryopreservation media market by geography

5.3 Semen processing media

5.3.1 Global IVF semen processing media market by geography

5.4 Ovum processing media

5.4.1 Global IVF ovum processing media market by geography

5.5 Embryo culture media

5.5.1 Global IVF embryo culture media market by geography

CHAPTER 6 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY TECHNIQUE

6.1 Global IVF market, by technique, 2014-2020 ($Million)
6.2 Fresh embryo transfer technique

6.2.1 Drivers

6.2.1.1 trends of Delayed pregnancies
6.2.1.2 Growing rates of infertility

6.2.2 Restraints

6.2.2.1 Cost involved in the treatment
6.2.2.2 reimbursements issues with fresh embryo ivf cycles

6.2.3 Global fresh embryo IVF cycle market, by geography

6.3 Frozen Embryo Transfer technique (FER)

6.3.1 Reasons to use this technique
6.3.2 Advantages of Frozen egg IVF technique
6.3.3 Disadvantages of frozen egg IVF technique
6.3.4 Global frozen egg IVF cycle market, by geography

6.4 Donor Egg IVF technique

6.4.1 Benefits of donor egg IVF technique
6.4.2 Risks associated with donor egg IVF cycle technique
6.4.3 Global donor egg IVF cycle market by geography

CHAPTER 7 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY END USERS

7.1 Global IVF market by end user, 2014-2020 ($Million)
7.2 Hospitals

7.2.1 Global IVF hospitals market by geography

7.3 Surgical centers
7.4 Clinical research institutes

7.4.1 Global IVF clinical research institutes market by geography

7.5 Clinics

7.5.1 Global IVF Clinics market by geography

CHAPTER 8 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY GEOGRAPHY

8.1 North America

8.1.1 North America IVF devices and consumables market, by country

8.1.1.1 United States IVF devices and consumables market
8.1.1.2 Canada IVF devices and consumables market
8.1.1.3 Mexico IVF devices and consumables market

8.2 Europe

8.2.1 Europe IVF devices and consumables market, by component

8.2.1.1 Germany IVF devices and consumables market
8.2.1.2 France IVF devices and consumables market
8.2.1.3 United Kingdom IVF devices and consumables market
8.2.1.4 Other Europe IVF devices and consumables market

8.3 Asia-Pacific

8.3.1 Asia-Pacific IVF devices & consumables market, by component

8.3.1.1 India IVF devices & consumables market
8.3.1.2 China IVF devices & consumables market
8.3.1.3 Japan IVF devices & consumables market
8.3.1.4 Australia IVF devices & consumables market
8.3.1.5 other Asia-pacific IVF devices & consumables market

8.4 LAMEA

8.4.1 LAMEA IVF devices & consumables market, by component

8.4.1.1 Latin America IVF devices & consumables market
8.4.1.2 Middle East IVF devices & consumables market
8.4.1.3 Africa IVF devices & consumables market

CHAPTER 9 COMPANY PROFILE

9.1 Vitrolife AB

9.1.1 Company overview
9.1.2 Business performance
9.1.3 Strategic moves and developments
9.1.4 SWOT analysis of Vitrolife AB

9.2 EMD Serono, Inc.

9.2.1 Company overview
9.2.2 Business performance
9.2.3 Strategic moves and developments
9.2.4 SWOT analysis of EMD Serono, Inc.

9.3 Irvine Scientific

9.3.1 Company overview
9.3.2 Business performance
9.3.3 Strategic moves and developments
9.3.4 SWOT analysis of Irvine scientific

9.4 CooperSurgical, Inc. (Origio)

9.4.1 Company overview
9.4.2 Business performance
9.4.3 Strategic moves and developments
9.4.4 SWOT analysis of CooperSurgical, Inc.

9.5 Cook Medical, Inc.

9.5.1 Company overview
9.5.2 Strategic moves and developments
9.5.3 SWOT analysis of Cook medical, Inc.

9.6 Thermo Fisher Scientific Inc.

9.6.1 Company overview:
9.6.2 Business performance
9.6.3 Strategic moves and developments
9.6.4 SWOT analysis of Thermo Fisher Scientific, Inc.

9.7 Genea Biomedx

9.7.1 Company overview
9.7.2 Strategic moves and developments
9.7.3 SWOT Analysis of Genea Biomedx

9.8 Auxogyn, Inc.

9.8.1 Company overview
9.8.2 Strategic moves and developments

9.8.2.1 Primary strategies
9.8.2.2 Other strategies

9.8.3 SWOT Analysis of Auxogyn, Inc.

9.9 Oxford Gene Technology

9.9.1 Company overview
9.9.2 Strategic moves and developments
9.9.3 SWOT analysis of Oxford Gene Technology

9.10 Ovascience Inc.

9.10.1 Company overview
9.10.2 Business performance
9.10.3 Strategic moves and developments
9.10.4 SWOT analysis of OvaScience, Inc.